Dr. Wasserman answers the question: 'Will I Need Oxygen If I Get Asthma?' — -- Question: Will I need oxygen if I get asthma? Answer: The use of oxygen in asthma is generally not a required ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Amgen today announced TEZSPIRE™ (tezepelumab-ekko) is now available for shipment to wholesalers in the US. TEZSPIRE was approved by the US Food and ...

In December 2021, the US Food and Drug Administration (FDA) approved Tezspire (tezepelumab-ekko; Amgen, Inc and AstraZeneca AB), a thymic stromal lymphopoietin (TSLP) blocker, for the add-on ...

Children who presented to the ED with severe asthma were eligible to enter the study. Severe asthma was classified as having all four features of respiratory distress (wheezing, sternal retraction, ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Amgen’s TEZSPIRE (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years ...

(RTTNews) - Vapotherm, Inc. (VAPO) reported the presentation of an Investigator-initiated clinical trial, "High flow humidified oxygen as an early intervention in children with acute severe asthma - a ...

May 6 is World Asthma Day. Asthma that occurred in adulthood is difficult to cure, while most children's asthma naturally gets better after puberty. However, if not treated properly, lung function is ...

Improvement across all asthma control parameters was achieved after 12 months of biologic treatment, according to one study. Patients with severe asthma treated with either omalizumab, benralizumab, ...

Please provide your email address to receive an email when new articles are posted on . Risk and annualized rate of severe exacerbations dropped with as-needed use of albuterol-budesonide vs.

Vapotherm Inc (NASDAQ:VAPO) announced the presentation of an investigator-initiated clinical trial at the European Respiratory Society International Congress 2023, a "high flow humidified oxygen as an ...

Rochester, Minn.-based Mayo Clinic researchers have developed AI tools to help identify young children at highest risk for severe asthma and acute respiratory infections. The tools use machine ...